Toggle light / dark theme

Making New Drugs With a Dose of Artificial Intelligence

Universities and big pharmaceutical companies are unlikely to match those resources. But thanks to cloud computing services offered by Google and other tech giants, the price of computing power continues to drop. Dr. AlQuraishi urged the life-sciences community to shift more attention toward the kind of A.I. work practiced by DeepMind.


Researchers at DeepMind, owned by Google’s parent company, and other companies are applying their powerful A.I. systems to drug discovery research.

Read more

Leave a Comment

If you are already a member, you can use this form to update your payment info.

Lifeboat Foundation respects your privacy! Your email address will not be published.